Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes
Jan 27 2023
•
By
Brenda Sandburg
The USPTO and FDA were advised on patent policy changes to prevent unjustified delays in competition. • Source: Shutterstock
More from Legal & IP
More from Pink Sheet